RNWHX
Price
$83.99
Change
+$0.62 (+0.74%)
Updated
Jun 2 closing price
Net Assets
66.97B
RREMX
Price
$14.60
Change
+$0.12 (+0.83%)
Updated
Jun 2 closing price
Net Assets
4.42B
Interact to see
Advertisement

RNWHX vs RREMX

Header iconRNWHX vs RREMX Comparison
Open Charts RNWHX vs RREMXBanner chart's image
American Funds New World R5E
Price$83.99
Change+$0.62 (+0.74%)
VolumeN/A
Net Assets66.97B
RBC Emerging Markets Equity R6
Price$14.60
Change+$0.12 (+0.83%)
VolumeN/A
Net Assets4.42B
RNWHX vs RREMX Comparison Chart
Loading...
View a ticker or compare two or three
VS
RNWHX vs. RREMX commentary
Jun 04, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is RNWHX is a Buy and RREMX is a StrongBuy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RNWHX has more cash in the bank: 67B vs. RREMX (4.42B). RNWHX pays higher dividends than RREMX: RNWHX (1.04) vs RREMX (0.85). RNWHX was incepted earlier than RREMX: RNWHX (10 years) vs RREMX (9 years). RREMX (0.88) is less costly to investors than RNWHX (0.72). RNWHX is a more actively managed with annual turnover of: 37.00 vs. RREMX (34.00). RNWHX has a lower initial minimum investment than RREMX: RNWHX (250) vs RREMX (250000). RREMX annual gain was more profitable for investors over the last year : 12.07 vs. RNWHX (8.13). RREMX return over 5 years is better than : 35.62 vs. RNWHX (30.39).
RNWHXRREMXRNWHX / RREMX
Total Expense Ratio0.720.8882%
Annual Report Gross Expense Ratio0.720.8882%
Fund Existence10 years9 years-
Gain YTD10.4849.863106%
Front LoadN/AN/A-
Min. Initial Investment2502500000%
Min. Initial Investment IRAN/AN/A-
Net Assets67B4.42B1,515%
Annual Yield % from dividends1.040.85123%
Returns for 1 year8.1312.0767%
Returns for 3 years23.2025.4191%
Returns for 5 years30.3935.6285%
Returns for 10 yearsN/AN/A-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
AVURX7.84N/A
N/A
American Century Value R
SSDIX33.18N/A
N/A
DWS Small Cap Growth Inst
JGECX12.25N/A
N/A
JHancock Global Equity C
THISX74.49N/A
N/A
T. Rowe Price Health Sciences I
FCGPX19.72N/A
N/A
NYLI PineStone Global Equity Class P